Evidence map›Paper›PMID 36514036›Full record

SynthesisBMC public health2022

Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa.

K Sabapathy, L Balzer, J Larmarange, L Block, S Floyd, C Iwuji, K Wirth, H Ayles, S Fidler, M Kamya and 5 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 6 countries.

K SabapathyLondon School of Hygiene and Tropical Medicine, London, UK. kalpana.sabapathy@lshtm.ac.uk.
L BalzerUniversity of California Berkeley, Berkeley, USA.
J LarmarangeCentre Population et Développement, Université Paris Cité & Institut de Recherche pour le Développement, Inserm, Paris, France.
L BlockCenters for Disease Control & Prevention, Atlanta, USA.
S FloydLondon School of Hygiene and Tropical Medicine, London, UK.
C IwujiAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
K WirthHarvard School of Public Health, Boston, MA, USA.
H AylesLondon School of Hygiene and Tropical Medicine, London, UK.
S FidlerImperial College London, London, UK.
M KamyaInfectious Disease Research Collaboration, Kampala, Uganda.
M PetersenUniversity of California Berkeley, Berkeley, USA.
D HavlirUniversity of California San Francisco, San Francisco, USA.
F DabisBordeaux University, Bordeaux, France.
J MooreCenters for Disease Control & Prevention, Atlanta, USA.
R HayesLondon School of Hygiene and Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBCenters for Disease Control and Prevention · USUniversity of California, Berkeley · USAfrica Health Research Institute · ZAHarvard University · USImperial College London · GBInserm · FRMakerere University · UGUniversité de Bordeaux · FRUniversity of California, San Francisco · US

Funding

Medical Research Council MR/R010161/1PEPFAR
6 · The paper itself

Abstract

backgroundFour large community-randomized trials examining universal testing and treatment (UTT) to reduce HIV transmission were conducted between 2012-2018 in Botswana, Kenya, Uganda, Zambia and South Africa. In 2014, the UNAIDS 90-90-90 targets were adopted as a useful metric to monitor coverage. We systematically review the approaches used by the trials to measure intervention delivery, and estimate coverage against the 90-90-90 targets. We aim to provide in-depth understanding of the background contexts and complexities that affect estimation of population-level coverage related to the 90-90-90 targets.

methodsEstimates were based predominantly on "process" data obtained during delivery of the interventions which included a combination of home-based and community-based services. Cascade coverage data included routine electronic health records, self-reported data, survey data, and active ascertainment of HIV viral load measurements in the field.

resultsThe estimated total adult populations of trial intervention communities included in this study ranged from 4,290 (TasP) to 142,250 (Zambian PopART Arm-B). The estimated total numbers of PLHIV ranged from 1,283 (TasP) to 20,541 (Zambian PopART Arm-B). By the end of intervention delivery, the first-90 target (knowledge of HIV status among all PLHIV) was met by all the trials (89.2%-94.0%). Three of the four trials also achieved the second- and third-90 targets, and viral suppression in BCPP and SEARCH exceeded the UNAIDS target of 73%, while viral suppression in the Zambian PopART Arm-A and B communities was within a small margin (~ 3%) of the target.

conclusionsAll four UTT trials aimed to implement wide-scale testing and treatment for HIV prevention at population level and showed substantial increases in testing and treatment for HIV in the intervention communities. This study has not uncovered any one estimation approach which is superior, rather that several approaches are available and researchers or policy makers seeking to measure coverage should reflect on background contexts and complexities that affect estimation of population-level coverage in their specific settings. All four trials surpassed UNAIDS targets for universal testing in their intervention communities ahead of the 2020 milestone. All but one of the trials also achieved the 90-90 targets for treatment and viral suppression. UTT is a realistic option to achieve 95-95-95 by 2030 and fast-track the end of the HIV epidemic.

Indexed as

EpidemicsHIV InfectionsAdultHIV TestingHumansRandomized Controlled Trials as TopicSouth AfricaZambiaAntiretroviral treatmentHIVTreatment as PreventionUNAIDS 90-90-90Universal Testing and Treatment

Identifiers

PMID36514036
PMCPMC9746009
OpenAlexW4312019728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.